Investor Relations News / Events Press Releases IR Calendar Email Alerts Press Releases All News 2020 2019 2018 2017 2016 2015 2014 iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference Jun 5, 2017 iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting May 4, 2017 Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action Jan 27, 2017 Another iBio Plague Vaccine Patent Issues Nov 21, 2016 iBio Expands Product Development Capacity of cGMP Plant Nov 10, 2016 iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd Sep 29, 2016 Implications of Court Decision in Favor of iBio Against Fraunhofer Aug 15, 2016 iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court Aug 4, 2016 iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate Jul 5, 2016 iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Jun 29, 2016 1 2 3 4 5 6 7 8
iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference Jun 5, 2017
iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd Sep 29, 2016
iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Jun 29, 2016
